Search Results

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
Immune Oncology Research Institute
Feb 13, 2024, 01:57 | Blog
Gevorg Tamamyan: It is a great honor to co-chair the "Cancer Research and Progress" Abstract Committee Theme at the World Cancer Congress 2024
Gevorg Tamamyan shared a post on LinkedIn: "It is a great honor to co-chair the…
Jan 21, 2024, 18:56 | Career
Our first podcast episode is airing on streaming platforms - Advanced Oncology
Advanced Oncology shared on their LinkedIn page: "Our first podcast episode is airing on streaming…
Jan 15, 2024, 08:37 | Career
Jemma Arakelyan: I have been ranked in the top 5% of PG researchers and have received Excellent Paper Awards
Jemma Arakelyan, CEO of the Institute of Cancer and Crisis, shared on LinkedIn: "Delighted to…
Dec 24, 2023, 12:49 | Opinion
Cancer research and treatment priorities for 2024: NCI's new director talks to cancer community
Dr. Kimryn Rathmell, the new Director of the US National Cancer Institute (NCI), asked on…
Nov 28, 2023, 16:14 | Blog
“The Immuno-Oncology Curve" with Dr. Steven O'Day - Guest is Alexander (Lex) Eggermont
Steven O'Day, the Chief Medical Officer of Agenus, shared on LinkedIn: "I’m excited to announce…
Nov 6, 2023, 01:07 | Blog
Ulrike Köhl: In less than a week our Leipzig Immunoncology (LION) Conference will start
Ulrike Köhl, Director of Fraunhofer Institute for Cell Therapy and Immunology Leipzig, made the following…
Oct 30, 2023, 13:42 | Positive
100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2023
Starting from August 26, which is Women’s Equality Day in the United States—celebrating the 1920…
Oct 21, 2023, 21:40 | Positive
100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2023: Part 9
We continue OncoDaily’s ‘100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social…
Oct 14, 2023, 18:26 | Blog
VIGex: a VHIO-developed predictive, pan-cancer platform to help guide patient selection for personalized immunotherapy. - Vall d'Hebron Institute of Oncology
Quoting Vall d'Hebron Institute of Oncology on LinkedIn: "VIGex: a VHIO-developed predictive, pan-cancer platform to…
Aug 10, 2023, 04:52 | Blog
World-renowned cancer experts, young oncology leaders and prominent patient advocates join the Editorial Board of OncoDaily
It is a great pleasure to introduce the new Editorial Board Members of OncoDaily.com! World-renowned…
All: 219 Posts: 41 - 50
Special Coverage